TGF-β in Renal Injury and Disease
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2007/05/01
-
Journal
-
Indian UGC (journal)
-
Refrences121
-
Citations261
-
Erwin P. Böttinger
Cite
Böttinger, Erwin P. “TGF-β in Renal Injury and Disease”. Seminars in Nephrology, vol. 27, no. 3, 2007, pp. 309-20, https://doi.org/10.1016/j.semnephrol.2007.02.009.
Böttinger, E. P. (2007). TGF-β in Renal Injury and Disease. Seminars in Nephrology, 27(3), 309-320. https://doi.org/10.1016/j.semnephrol.2007.02.009
Böttinger EP. TGF-β in Renal Injury and Disease. Seminars in Nephrology. 2007;27(3):309-20.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
You May Also Like
- Proinflammatory actions of angiotensins
- Cell biology and molecular mechanisms of injury in ischemic acute renal failure
- Prediction equations to estimate glomerular filtration rate: an update
- The Banff 97 working classification of renal allograft pathology
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Mediators of diabetic renal disease: the case for TGF-beta as the major mediator | 2004 | |||
Proapoptotic Bid is required for pulmonary fibrosis | Proceedings of the National Academy of Sciences |
| 87 | 2006 |
| Essential role of Smad3 in angiotensin II-induced vascular fibrosis | Circulation Research |
| 2006 | |
| Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis | Cytokine & Growth Factor Reviews |
| 235 | 2006 |
| Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling | Proceedings of the American Thoracic Society |
| 2006 |
Refrences Analysis
The category
Medicine: Medicine (General) 39
is the most frequently represented among the references in this article. It primarily includes studies from Kidney International The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1 | Endocrine |
| 2024 | |
| Mechanisms of norcantharidin against renal tubulointerstitial fibrosis | Pharmacological Reports |
| 2024 | |
| Dohongsamul-tang inhibits cardiac remodeling and fibrosis through calcineurin/NFAT and TGF-β/Smad2 signaling in cardiac hypertrophy | Journal of Ethnopharmacology |
| 2024 | |
| Neuroinflammatory mediators in acquired epilepsy: an update | Inflammation Research |
| 16 | 2023 |
Ceratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats | Environmental Science and Pollution Research |
| 7 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 134
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury and was published in 2008. The most recent citation comes from a 2024 study titled Mechanisms of norcantharidin against renal tubulointerstitial fibrosis. This article reached its peak citation in 2015, with 24 citations. It has been cited in 134 different journals, 28% of which are open access. Among related journals, the American Journal of Physiology-Renal Physiology cited this research the most, with 17 citations. The chart below illustrates the annual citation trends for this article.